Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Paclitaxel Solution as Neoadjuvant Therapy in Elderly NSCLC
NCT07599163Phase 2Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Jun 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel oral solution in non-small cell lung cancer (NSCLC), sponsored by Shanghai Pulmonary Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
paclitaxel oral solution
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07599163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07599163.